ALZAI Health Corp. begins trading on US OTCQB Venture Market

ALZAI Health Corp., a health technology company specializing in artificial intelligence-based solutions for disease risk detection, has commenced trading of its common shares on the OTCQB Venture Market in the United States under the symbol ALZIF.

The company’s proprietary platform utilizes non-invasive, AI-driven methods to identify individuals at high risk of disease before a clinical diagnosis, facilitating early intervention. ALZAI’s technology is designed for integration into existing healthcare infrastructures, including electronic health records and cloud environments.

In addition to the new US listing, ALZAI’s common shares continue to trade on the TSX Venture Exchange under the symbol ALZI and on the Frankfurt Stock Exchange under the symbol H2F.